The market is driven by factors, such as technological advancements and
innovations, increasing compliance for drug discovery processes, and high
demand for organ and tissue transplantation.
The 3D bioprinting finds application in government tissue & organ
regeneration, 3D cell culture, pharmaceutical, and others. The tissue and organ
regeneration segment accounted for the major share in the 3D bioprinting market
in 2015; whereas, 3D cell culture witnessed the fastest growth.
Request for a
sample: https://www.psmarketresearch.com/market-analysis/3d-bioprinting-market/report-sample
Asia-Pacific would be the fastest growing region in the 3D bioprinting market during 2016 - 2022. The region accounted for 20.0% share in the global market in 2015 and the share is expected to increase to 23.2% by 2022. The major reasons behind the fastest growth of the market in the region include increasing stem cell research, huge gap in demand supply for tissue and organ transplant, improving healthcare infrastructure, increasing prevalence of chronic diseases, technological advancements and increasing geriatric population.
Make enquiry before
buying the report: https://www.psmarketresearch.com/send-enquiry?enquiry-url=3d-bioprinting-market
3D bioprinting has opened up new platforms in the drug discovery and
development process. Many drugs are withdrawn or not approved by regulatory
authority due to their toxicity to certain organ such as liver, which could not
be predicted during the pre-clinical trial process. Tissues developed through
3D bioprinting such as liver tissue help to predict drug toxicity and improve
drug efficacy. Moreover, 3D bioprinting also saves time in clinical trials,
thus, increasing its compliance for drug discovery. Different Pharmaceutical
companies are collaborating with 3D bioprinting companies to test their drugs
in early stage of clinical trials. New drugs are tested for their efficacy on
3D printed tissues in the initial stages; thus, speeding up the drug discovery
process. Owing to the aforementioned factor the 3D bioprinting market is gaining
huge traction across the pharmaceutical industry.
Some of the major players operating in the 3D bioprinting market include Organovo
Holdings, Inc., CELLINK, EnvisionTEC, BioBots, Cyfuse Biomedical K.K., Aspect
Biosystems Ltd., 3D Bioprinting Solutions, Ourobotics, Advanced Solutions,
Inc., GeSiM, Bio3D Technologies, 3Dynamic Systems Ltd., Nano3D Biosciences,
Inc., Poietis, regenHU Ltd., and Aerotech Inc.